The effect of the 5-HT3-receptor antagonist tropisetron on the pain caused by secondary fibromyalgia;Die schmerzbeeinflussung durch den 5-HT3-rezeptorantagonisten tropisetron bei sekundären fibromyalgien

MMW-Fortschritte der Medizin

Volumn 144, Issue SUPPL. 1, 2002, Pages 17-20

  Stratz, Thomas ^a   Muller W ^a  

^a Hochrhein Inst fur Rehab Forsch   (Germany)

Author keywords

5 HT3 receptor antagonist; Open study; Secondary fibromyalgia

Indexed keywords

METHYLPREDNISOLONE; SEROTONIN 3 ANTAGONIST; TROPISETRON;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBROMYALGIA; HUMAN; PAIN; PAIN ASSESSMENT; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 0037171768     PISSN: 14383276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems
2. Somatotopic activation of opioid systems by target-directed expectations of analgesia
3. Efficacy and tolerability of tropisetron in primary fibromyalgia - A highly seletive and competitive 5-HT3 receptor antagonist
4. Oral treatment of fibromyalgia with tropisetron given over 28 days: Influence on functionaland vegetative symptoms, psychometric parameters and pain
5. Intraneuronal substance P contributes to the severity of experimental arthritis
6. Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis
7. Substance P levels in the synovium fluid from patients with rheumatoid arthritis and osteoarthritis
8. Neue aspekte in der medikamentösen therapie der fibromyalgie
9. Paracetamol with and without codeine in acute pain: A quantitative systematic review
10. Die therapie der sekundären fibromyalgie durch blockierungder 5-HT3-rezeptoren bei der chronischen polyarthritis
11. The use of 5-HT3 receptor antagonists in various rheumatic diseases - A clue to the mechanism of action of these agents in fibromyalgia?
12. Die therapie der generalisierten tendomyopathie (Fibromyalgie) durch blockierung der 5-HT3-rezeptoren
13. The importance of placebo effects in pain treatment and research
14. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis